IDEAYA Biosciences, Inc. - stock earnings
IDYA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -34.0 million USD | 3.9 million USD |
| 2023Q3 | -27.4 million USD | 8.0 million USD |
| 2023Q2 | -27.9 million USD | 3.5 million USD |
| 2023Q1 | -20.0 million USD | 7.9 million USD |
| 2022Q4 | -22.0 million USD | 4.0 million USD |
| 2022Q3 | 2.6 million USD | 29.7 million USD |
| 2022Q2 | -21.6 million USD | 5.9 million USD |
| 2022Q1 | -18.0 million USD | 11.4 million USD |
| 2021Q4 | -18.2 million USD | 3.0 million USD |
| 2021Q3 | -11.6 million USD | 9.0 million USD |
| 2021Q2 | -10.9 million USD | 8.8 million USD |
| 2021Q1 | -9.0 million USD | 7.2 million USD |
| 2020Q4 | -5.1 million USD | 10.6 million USD |
| 2020Q3 | -4.9 million USD | 9.0 million USD |
| 2020Q2 | -12.4 million USD | ? USD |
| 2020Q1 | -12.0 million USD | ? USD |
| 2019Q4 | -10.8 million USD | ? USD |
| 2019Q3 | -11.0 million USD | ? USD |
| 2019Q2 | -10.7 million USD | ? USD |
| 2019Q1 | -9.6 million USD | ? USD |
| 2018Q4 | -8.6 million USD | ? USD |
| 2018Q3 | -13.1 million USD | ? USD |
| 2018Q2 | -7.0 million USD | ? USD |
| 2018Q1 | -5.7 million USD | ? USD |
IDYA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -113.0 million USD | 23.4 million USD |
| 2022 | -54.8 million USD | 50.9 million USD |
| 2021 | -47.5 million USD | 27.9 million USD |
| 2020 | -32.3 million USD | 19.5 million USD |
| 2019 | -38.4 million USD | ? USD |
| 2018 | -34.3 million USD | ? USD |
| 2017 | -11.9 million USD | ? USD |
IDYA
Price: $42.18
52 week price:
Earnings Per Share: -1.96 USD
P/E Ratio: -23.10
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 546053
Market Capitalization: 3.2 billion